Payment overview · 2025
General Payments
$14.20
1 reported records · 1 companies
Healthcare provider profile · identity verified
Shoaib Khalil, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · CLEBURNE, TX · NPI 1003857459
Verified facts
What the public records show
CMS Open Payments records show Shoaib Khalil, M.D. received $14.20 in general payments during 2025 across 1 reported records.
Novo Nordisk Inc accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Ozempic, Rybelsus.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 159 claims for Ozempic by this doctor in 2024.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Rybelsus as an associated drug or biological on 161257 records involving 55409 distinct recipient NPIs. Public Medicare Part D data also shows 69 claims for Rybelsus by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Novo Nordisk Inc | Unresolved — no canonical attribution shown | $14.20 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $14.20 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Ozempic Normalized: ozempic |
Drug | Novo Nordisk Inc | $14.20 | 1 | 2025 |
Source payment records
|
|||||
| Rybelsus Normalized: rybelsus |
Drug | Novo Nordisk Inc | $14.20 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| Ozempic ozempic |
2025 | Ozempic | 2024 | 159 | exact normalized | Medicare Part D |
| Rybelsus rybelsus |
2025 | Rybelsus | 2024 | 69 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Ozempic open payments reported associated product |
CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076 |
Ozempic · 2024 Exact normalized brand match · 1 Part D row |
159 | 34 |
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Rybelsus open payments reported associated product |
CMS Open Payments — General Payments 161257 supporting records · 55409 recipient NPIs · example record 1188130076 |
Rybelsus · 2024 Exact normalized brand match · 1 Part D row |
69 | 21 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 580 | 163 |
| Pantoprazole Sodium | Pantoprazole Sodium | 565 | 163 |
| Amlodipine Besylate | Amlodipine Besylate | 538 | 162 |
| Losartan Potassium | Losartan Potassium | 531 | 161 |
| Gabapentin | Gabapentin | 499 | 141 |
| Levothyroxine Sodium | Levothyroxine Sodium | 463 | 122 |
| Metoprolol Succinate | Metoprolol Succinate | 364 | 101 |
| Prednisone | Prednisone | 349 | 182 |
| Celecoxib | Celecoxib | 318 | 102 |
| Carvedilol | Carvedilol | 316 | 89 |
| Metformin Hcl | Metformin Hcl | 304 | 80 |
| Lisinopril | Lisinopril | 294 | 84 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 280 | 81 |
| Metoprolol Tartrate | Metoprolol Tartrate | 252 | 60 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 251 | 94 |
| Tamsulosin Hcl | Tamsulosin Hcl | 244 | 82 |
| Azithromycin | Azithromycin | 239 | 179 |
| Duloxetine Hcl | Duloxetine Hcl | 224 | 56 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 223 | 67 |
| Furosemide | Furosemide | 221 | 72 |
| Omeprazole | Omeprazole | 204 | 49 |
| Tizanidine Hcl | Tizanidine Hcl | 202 | 76 |
| Montelukast Sodium | Montelukast Sodium | 200 | 61 |
| Potassium Chloride | Potassium Chloride | 200 | 60 |
| Sertraline Hcl | Sertraline Hcl | 197 | 58 |
| Jardiance | Empagliflozin | 195 | 49 |
| Glipizide Er | Glipizide | 190 | 62 |
| Tramadol Hcl | Tramadol Hcl | 182 | 42 |
| Eliquis | Apixaban | 172 | 45 |
| Simvastatin | Simvastatin | 161 | 36 |
| Ozempic | Semaglutide | 159 | 34 |
| Trazodone Hcl | Trazodone Hcl | 158 | 57 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 153 | 47 |
| Pregabalin | Pregabalin | 150 | 35 |
| Citalopram Hbr | Citalopram Hydrobromide | 146 | 44 |
| Pravastatin Sodium | Pravastatin Sodium | 143 | 39 |
| Hydrochlorothiazide | Hydrochlorothiazide | 142 | 40 |
| Fluticasone Propionate | Fluticasone Propionate | 140 | 52 |
| Clopidogrel | Clopidogrel Bisulfate | 139 | 44 |
| Escitalopram Oxalate | Escitalopram Oxalate | 139 | 47 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 134 | 39 |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 115 | 76 |
| Fenofibrate | Fenofibrate Nanocrystallized | 108 | 27 |
| Valsartan | Valsartan | 108 | 34 |
| Alprazolam | Alprazolam | 102 | 22 |
| Clonazepam | Clonazepam | 99 | 19 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 99 | 26 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 97 | 43 |
| Famotidine | Famotidine | 96 | 26 |
| Ropinirole Hcl | Ropinirole Hcl | 95 | 22 |
| Topiramate | Topiramate | 95 | 21 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 92 | 24 |
| Zolpidem Tartrate | Zolpidem Tartrate | 90 | 16 |
| Cephalexin | Cephalexin | 88 | 53 |
| Ezetimibe | Ezetimibe | 86 | 22 |
| Metformin Hcl Er | Metformin Hcl | 81 | 30 |
| Temazepam | Temazepam | 79 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 78 | 60 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 77 | 19 |
| Spironolactone | Spironolactone | 76 | 23 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 73 | 22 |
| Olanzapine | Olanzapine | 71 | 18 |
| Propranolol Hcl | Propranolol Hcl | 69 | 27 |
| Rybelsus | Semaglutide | 69 | 21 |
| Glipizide | Glipizide | 67 | 18 |
| Estradiol | Estradiol | 66 | 14 |
| Myrbetriq | Mirabegron | 66 | 16 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 65 | 18 |
| Meloxicam | Meloxicam | 65 | suppressed |
| Trulicity | Dulaglutide | 62 | 15 |
| Amitriptyline Hcl | Amitriptyline Hcl | 61 | 19 |
| Chlorthalidone | Chlorthalidone | 60 | 20 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 60 | 45 |
| Allopurinol | Allopurinol | 59 | 17 |
| Buspirone Hcl | Buspirone Hcl | 59 | 21 |
| Symbicort | Budesonide/Formoterol Fumarate | 59 | 23 |
| Memantine Hcl | Memantine Hcl | 58 | 27 |
| Ondansetron Hcl | Ondansetron Hcl | 58 | 33 |
| Solifenacin Succinate | Solifenacin Succinate | 58 | 23 |
| Etodolac | Etodolac | 56 | 15 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 56 | 26 |
| Glimepiride | Glimepiride | 55 | 20 |
| Diclofenac Sodium | Diclofenac Sodium | 54 | 28 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 54 | 18 |
| Fluoxetine Hcl | Fluoxetine Hcl | 53 | 17 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 53 | 29 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 52 | 45 |
| Terbinafine Hcl | Terbinafine Hcl | 52 | 30 |
| Amoxicillin | Amoxicillin | 51 | 41 |
| Hydralazine Hcl | Hydralazine Hcl | 51 | 15 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 50 | 28 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 50 | 13 |
| Pioglitazone Hcl | Pioglitazone Hcl | 50 | 18 |
| Eszopiclone | Eszopiclone | 49 | suppressed |
| Fenofibrate | Fenofibrate | 49 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 49 | 11 |
| Alendronate Sodium | Alendronate Sodium | 48 | suppressed |
| Baclofen | Baclofen | 47 | suppressed |
| Diazepam | Diazepam | 47 | suppressed |
| Mounjaro | Tirzepatide | 47 | suppressed |
| Bupropion Xl | Bupropion Hcl | 46 | 14 |
| Ibandronate Sodium | Ibandronate Sodium | 44 | 18 |
| Ondansetron Odt | Ondansetron | 44 | 19 |
| Doxazosin Mesylate | Doxazosin Mesylate | 43 | 13 |
| Amiodarone Hcl | Amiodarone Hcl | 42 | 12 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 42 | 16 |
| Linzess | Linaclotide | 42 | suppressed |
| Mirtazapine | Mirtazapine | 42 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 42 | 13 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 41 | 11 |
| Oxybutynin Chloride | Oxybutynin Chloride | 40 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 39 | 13 |
| Finasteride | Finasteride | 38 | 12 |
| Levetiracetam | Levetiracetam | 38 | suppressed |
| Lovastatin | Lovastatin | 38 | 11 |
| Rabeprazole Sodium | Rabeprazole Sodium | 38 | 12 |
| Fluconazole | Fluconazole | 37 | 32 |
| Januvia | Sitagliptin Phosphate | 36 | 12 |
| Nystatin | Nystatin | 36 | 26 |
| Xarelto | Rivaroxaban | 35 | suppressed |
| Irbesartan | Irbesartan | 34 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 34 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 33 | 13 |
| Hydrocortisone | Hydrocortisone | 33 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 32 | suppressed |
| Lorazepam | Lorazepam | 29 | suppressed |
| Methocarbamol | Methocarbamol | 29 | 15 |
| Quetiapine Fumarate | Quetiapine Fumarate | 29 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 28 | suppressed |
| Humulin 70/30 Kwikpen | Insulin Nph Hum/Reg Insulin Hm | 28 | suppressed |
| Nifedipine Er | Nifedipine | 28 | suppressed |
| Torsemide | Torsemide | 28 | suppressed |
| Mupirocin | Mupirocin | 27 | 20 |
| Nateglinide | Nateglinide | 27 | suppressed |
| Synthroid | Levothyroxine Sodium | 27 | suppressed |
| Betamethasone Valerate | Betamethasone Valerate | 26 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 26 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 25 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 25 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 25 | 17 |
| Methotrexate | Methotrexate Sodium | 25 | suppressed |
| Novolin 70-30 Flexpen | Insulin Nph Hum/Reg Insulin Hm | 25 | suppressed |
| Acyclovir | Acyclovir | 24 | 11 |
| Midodrine Hcl | Midodrine Hcl | 24 | suppressed |
| Dutasteride | Dutasteride | 23 | suppressed |
| Entresto | Sacubitril/Valsartan | 23 | suppressed |
| Lactulose | Lactulose | 23 | suppressed |
| Metolazone | Metolazone | 23 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 23 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 22 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 22 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 22 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 21 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 21 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 21 | 12 |
| Diltiazem Hcl | Diltiazem Hcl | 21 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 21 | suppressed |
| Ketoconazole | Ketoconazole | 21 | 16 |
| Nitroglycerin | Nitroglycerin | 21 | 14 |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 20 | suppressed |
| Digoxin | Digoxin | 19 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 19 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 18 | suppressed |
| Lamotrigine | Lamotrigine | 18 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 18 | suppressed |
| Metronidazole | Metronidazole | 18 | 16 |
| Azelastine Hcl | Azelastine Hcl | 17 | suppressed |
| Cefdinir | Cefdinir | 17 | 17 |
| Phenytoin | Phenytoin | 17 | suppressed |
| Scopolamine | Scopolamine | 17 | suppressed |
| Enalapril-Hydrochlorothiazide | Enalapril/Hydrochlorothiazide | 16 | suppressed |
| Ibuprofen | Ibuprofen | 16 | suppressed |
| Levofloxacin | Levofloxacin | 16 | 14 |
| Rufinamide | Rufinamide | 16 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 16 | suppressed |
| Advair Hfa | Fluticasone Propion/Salmeterol | 15 | suppressed |
| Brilinta | Ticagrelor | 15 | suppressed |
| Bumetanide | Bumetanide | 15 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 15 | suppressed |
| Sucralfate | Sucralfate | 15 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 15 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 14 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 14 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 14 | suppressed |
| Humalog Kwikpen U-200 | Insulin Lispro | 14 | suppressed |
| Jantoven | Warfarin Sodium | 14 | suppressed |
| Lansoprazole | Lansoprazole | 14 | suppressed |
| Tradjenta | Linagliptin | 14 | suppressed |
| Ulticare Pen Needle | Pen Needle, Diabetic | 14 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 14 | suppressed |
| Buprenorphine | Buprenorphine | 13 | suppressed |
| Calcitonin-Salmon | Calcitonin,salmon,synthetic | 13 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 13 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 13 | 12 |
| Diltiazem 12hr Er | Diltiazem Hcl | 13 | suppressed |
| Humulin R U-500 Kwikpen | Insulin Regular, Human | 13 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 13 | suppressed |
| Novolog Flexpen | Insulin Aspart | 13 | suppressed |
| Primidone | Primidone | 13 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 13 | suppressed |
| Verapamil Er | Verapamil Hcl | 13 | suppressed |
| Breyna | Budesonide/Formoterol Fumarate | 12 | suppressed |
| Desmopressin Acetate | Desmopressin Acetate | 12 | suppressed |
| Methylphenidate Hcl | Methylphenidate Hcl | 12 | suppressed |
| Nurtec Odt | Rimegepant Sulfate | 12 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 12 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 12 | suppressed |
| Rizatriptan | Rizatriptan Benzoate | 12 | suppressed |
| Synjardy Xr | Empagliflozin/Metformin Hcl | 12 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 12 | suppressed |
| Zonisamide | Zonisamide | 12 | suppressed |
| Amlodipine-Valsartan | Amlodipine Besylate/Valsartan | 11 | suppressed |
| Ammonium Lactate | Ammonium Lactate | 11 | suppressed |
| Atenolol | Atenolol | 11 | suppressed |
| Bromocriptine Mesylate | Bromocriptine Mesylate | 11 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 11 | suppressed |
| Humalog Mix 75-25 Kwikpen | Insulin Lispro Protamin/Lispro | 11 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 11 | suppressed |
| Pentasa | Mesalamine | 11 | suppressed |
| Ramipril | Ramipril | 11 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 11 | suppressed |
| Telmisartan | Telmisartan | 11 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $14.20 · 1 records | Novo Nordisk Inc | Ozempic, Rybelsus | 2 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Ozempic play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with Novo Nordisk Inc?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error